Administration of the non-selective nicotinic receptor antagonist mecamylamine increased the severity of acute pancreatitis, whereas administration of the α7nAChR agonist GTS-21 decreased the severity of acute pancreatitis (26). Here, CHRNA7 is linked to acute pancreatitis.